What happened
Genematrix reported separate results for FY2025: revenue of US$7.31M (+6.2% year on year), an operating loss of US$467K and a net loss of US$1.26M.
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$7.31M |
|---|---|
| Revenue vs a year earlier | +6.2% |
| Operating profit | −US$467K |
| Net income | −US$1.26M |
| Period | FY2025 (separate) |
| Filed | 2026-02-11, Change of 30% or more in revenue or profit/loss structure (15% for large companies) |
| Source | DART rcept 20260211900869 → open original filing |
Source: DART. Information only, not investment advice.